Tuesday, December 08, 2020 11:16:21 PM
https://www.globenewswire.com/news-release/2020/11/25/2134120/0/en/FDA-Approves-Y-mAbs-DANYELZA-naxitamab-gqgk-for-the-Treatment-of-Neuroblastoma.html
Recent YMAB News
- Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting • GlobeNewswire Inc. • 12/07/2024 05:00:00 PM
- Y-mAbs to Participate at Citi’s 2024 Global Healthcare Conference • GlobeNewswire Inc. • 11/27/2024 12:35:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:32:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 12:18:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 11:55:20 AM
- Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments • GlobeNewswire Inc. • 11/08/2024 11:35:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 01:51:28 PM
- Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan • GlobeNewswire Inc. • 11/04/2024 12:35:00 PM
- Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 10/25/2024 11:05:00 AM
- Y-mAbs to Participate in Upcoming Investor Conferences in October • GlobeNewswire Inc. • 10/01/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:16:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 08:15:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 12:05:37 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 09:24:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:19:43 PM
- Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer Research • GlobeNewswire Inc. • 09/06/2024 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 09:00:28 PM
- Y-mAbs to Participate in Upcoming Investor Conferences in September • GlobeNewswire Inc. • 09/03/2024 12:32:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 08:15:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/28/2024 09:12:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:05:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2024 08:12:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 11:06:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 10:50:43 AM
- Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments • GlobeNewswire Inc. • 08/12/2024 10:30:00 AM
VAYK Renewed JV to Renovate Historic Landmark into "Most Sought-after Airbnb Place" in Downtown Atlanta • VAYK • Dec 12, 2024 9:36 AM
Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN • SLXN • Dec 11, 2024 9:22 AM
Actelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market.. • ASNS • Dec 11, 2024 8:30 AM
Consumer Automotive Finance, Inc. Cancels an Additional 50 Million Common Shares with Shareholder Commitment to Retire 250 Million More Common Shares • CAFI • Dec 10, 2024 1:30 PM
Strategic Investments Spark Renewed Interest in Multi-Club Ownership Models • MSGS • Dec 10, 2024 1:11 PM
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance • CAFI • Dec 9, 2024 9:30 AM